Literature DB >> 26415911

microRNAs and Molecular Pathogenesis of Microcephaly.

Xuqing Liu1, Tao Sun.   

Abstract

Microcephaly is a clinical condition defined as a reduction in head circumference and brain volume. The abnormal brain size may result from pathological neural stem cell (NSC) proliferation, survival, differentiation and migration during the development of the cerebral cortex. This process is controlled by many factors, including microRNAs that normally silence target genes at the posttranscriptional level. In this review, we will discuss the roles of microRNAs involved in different stages of the cortical development to shed light on the pathogenesis of microcephaly. Understanding the molecular mechanisms of microRNA-mediated cortical development may help develop a means of microRNA-based diagnosis and treatment for microcephaly in humans.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26415911     DOI: 10.2174/1874467208666150928153949

Source DB:  PubMed          Journal:  Curr Mol Pharmacol        ISSN: 1874-4672            Impact factor:   3.339


  3 in total

Review 1.  Cerebral cortex expansion and folding: what have we learned?

Authors:  Virginia Fernández; Cristina Llinares-Benadero; Víctor Borrell
Journal:  EMBO J       Date:  2016-04-07       Impact factor: 11.598

2.  Counter-Balance Between Gli3 and miR-7 Is Required for Proper Morphogenesis and Size Control of the Mouse Brain.

Authors:  Longbin Zhang; Taufif Mubarak; Yase Chen; Trevor Lee; Andrew Pollock; Tao Sun
Journal:  Front Cell Neurosci       Date:  2018-08-17       Impact factor: 5.505

3.  A de novo variant in ADGRL2 suggests a novel mechanism underlying the previously undescribed association of extreme microcephaly with severely reduced sulcation and rhombencephalosynapsis.

Authors:  Myriam Vezain; Matthieu Lecuyer; Marina Rubio; Valérie Dupé; Leslie Ratié; Véronique David; Laurent Pasquier; Sylvie Odent; Sophie Coutant; Isabelle Tournier; Laetitia Trestard; Homa Adle-Biassette; Denis Vivien; Thierry Frébourg; Bruno J Gonzalez; Annie Laquerrière; Pascale Saugier-Veber
Journal:  Acta Neuropathol Commun       Date:  2018-10-19       Impact factor: 7.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.